Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 May;63(5):2054–2061. doi: 10.1128/iai.63.5.2054-2061.1995

Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.

D Islam 1, B Wretlind 1, M Ryd 1, A A Lindberg 1, B Christensson 1
PMCID: PMC173264  PMID: 7729920

Abstract

To assess the humoral immunological responses at the subclass level in shigellosis, specific antibody responses against Shigella dysenteriae 1 lipopolysaccharide (LPS), S. flexneri Y LPS, invasion plasmid-coded protein antigens (Ipa), and Shiga toxin were analyzed. Antibody responses of 41 patients with S. dysenteriae 1 infection (SDIP) and 15 patients with S. flexneri infection (SFIP) were compared with those of controls (n = 40). The levels of total immunoglobulin G (IgG), IgA, IgM, and albumin in serum and stool samples were analyzed. In addition, total IgA (t-IgA), secretory IgA (s-IgA), and antigen-specific s-IgA in fecal samples were analyzed to evaluate the specificities and magnitudes of the mucosal immune responses. By comparing the relative increases in optical density for each IgG subclass separately, it was determined that the anti-LPS (homologous) response initially increased in the order IgG2 > IgG1 > IgG3 > IgG4 and that this order changed to IgG2 > IgG3 > IgG1 > IgG4 later in the disease. The IgG subclass response against protein antigens initially showed the order IgG1 > IgG3 > IgG2 > IgG4, which changed to IgG3 > IgG1 > IgG2 > IgG4 later in the disease. A significant increase in the proportion of IgA2 among t-IgA compared with that in controls was seen in both SDIP and SFIP, while significant changes in the proportions of IgG1 and IgG2 among t-IgG compared with controls was seen only in SDIP. The anti-LPS IgA2 response was more prominent in SDIP than in SFIP. We found an early peak of antigen-specific s-IgA in fecal samples, with a shorter duration than the corresponding response in serum samples. The simultaneous increase of serum IgA, fecal t-IgA, and s-IgA in SDIP compared with those in SFIP suggests that there is a massive increase in the local IgA production, giving an increase in systemic IgA concomitant with an extensive gut mucosal inflammation leading to an increased loss of albumin, IgG, and IgA with a high ratio of t-IgA to s-IgA.

Full Text

The Full Text of this article is available as a PDF (262.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam A. N., Islam M. R., Hossain M. S., Mahalanabis D., Hye H. K. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children. Scand J Gastroenterol. 1994 Apr;29(4):313–317. doi: 10.3109/00365529409094842. [DOI] [PubMed] [Google Scholar]
  2. Baudry B., Maurelli A. T., Clerc P., Sadoff J. C., Sansonetti P. J. Localization of plasmid loci necessary for the entry of Shigella flexneri into HeLa cells, and characterization of one locus encoding four immunogenic polypeptides. J Gen Microbiol. 1987 Dec;133(12):3403–3413. doi: 10.1099/00221287-133-12-3403. [DOI] [PubMed] [Google Scholar]
  3. Black R. E., Levine M. M., Clements M. L., Losonsky G., Herrington D., Berman S., Formal S. B. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J Infect Dis. 1987 Jun;155(6):1260–1265. doi: 10.1093/infdis/155.6.1260. [DOI] [PubMed] [Google Scholar]
  4. Brandtzaeg P. Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections. J Infect Dis. 1992 Jun;165 (Suppl 1):S167–S176. doi: 10.1093/infdis/165-supplement_1-s167. [DOI] [PubMed] [Google Scholar]
  5. Brown T. A., Murphy B. R., Radl J., Haaijman J. J., Mestecky J. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol. 1985 Aug;22(2):259–264. doi: 10.1128/jcm.22.2.259-264.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buysse J. M., Stover C. K., Oaks E. V., Venkatesan M., Kopecko D. J. Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping. J Bacteriol. 1987 Jun;169(6):2561–2569. doi: 10.1128/jb.169.6.2561-2569.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cam P. D., Pál T., Lindberg A. A. Immune response against lipopolysaccharide and invasion plasmid-coded antigens of shigellae in Vietnamese and Swedish dysenteric patients. J Clin Microbiol. 1993 Feb;31(2):454–457. doi: 10.1128/jcm.31.2.454-457.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cohen D., Block C., Green M. S., Lowell G., Ofek I. Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. J Clin Microbiol. 1989 Jan;27(1):162–167. doi: 10.1128/jcm.27.1.162-167.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cohen D., Green M. S., Block C., Rouach T., Ofek I. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J Infect Dis. 1988 May;157(5):1068–1071. doi: 10.1093/infdis/157.5.1068. [DOI] [PubMed] [Google Scholar]
  10. Cohen D., Green M. S., Block C., Slepon R., Lerman Y. Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide. J Infect Dis. 1992 Apr;165(4):785–787. doi: 10.1093/infdis/165.4.785. [DOI] [PubMed] [Google Scholar]
  11. Cohen D., Green M. S., Block C., Slepon R., Ofek I. Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J Clin Microbiol. 1991 Feb;29(2):386–389. doi: 10.1128/jcm.29.2.386-389.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Colombel J. F., Rambaud J. C., Vaerman J. P., Galian A., Delacroix D. L., Nemeth J., Duprey F., Halphen M., Godeau P., Dive C. Massive plasma cell infiltration of the digestive tract. Secretory component as the rate-limiting factor of immunoglobulin secretion in external fluids. Gastroenterology. 1988 Oct;95(4):1106–1113. doi: 10.1016/0016-5085(88)90189-8. [DOI] [PubMed] [Google Scholar]
  13. Diabetic skin, joints, and eyes--how are they related? Lancet. 1987 Aug 8;2(8554):313–314. [PubMed] [Google Scholar]
  14. Fontaine A., Arondel J., Sansonetti P. J. Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1. Infect Immun. 1988 Dec;56(12):3099–3109. doi: 10.1128/iai.56.12.3099-3109.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gaspari M. M., Brennan P. T., Solomon S. M., Elson C. O. A method of obtaining, processing, and analyzing human intestinal secretions for antibody content. J Immunol Methods. 1988 May 25;110(1):85–91. doi: 10.1016/0022-1759(88)90086-5. [DOI] [PubMed] [Google Scholar]
  16. Hale T. L. Genetic basis of virulence in Shigella species. Microbiol Rev. 1991 Jun;55(2):206–224. doi: 10.1128/mr.55.2.206-224.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hale T. L., Oaks E. V., Formal S. B. Identification and antigenic characterization of virulence-associated, plasmid-coded proteins of Shigella spp. and enteroinvasive Escherichia coli. Infect Immun. 1985 Dec;50(3):620–629. doi: 10.1128/iai.50.3.620-629.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hammarström L., Persson M. A., Smith C. I. Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors. Immunology. 1985 Apr;54(4):821–826. [PMC free article] [PubMed] [Google Scholar]
  19. Hammarström L., Persson M. A., Smith C. I. Subclass distribution of human anti-Staphylococcus aureus alpha toxin antibodies: suggestion of an IgG1, IgA1, IgG4 switch pattern. Scand J Immunol. 1984 Sep;20(3):247–250. doi: 10.1111/j.1365-3083.1984.tb00998.x. [DOI] [PubMed] [Google Scholar]
  20. Hammarström L., Smith C. I. IgG subclass changes in response to vaccination. Monogr Allergy. 1986;19:241–252. [PubMed] [Google Scholar]
  21. High N., Mounier J., Prévost M. C., Sansonetti P. J. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 1992 May;11(5):1991–1999. doi: 10.1002/j.1460-2075.1992.tb05253.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Keusch G. T., Bennish M. L. Shigellosis: recent progress, persisting problems and research issues. Pediatr Infect Dis J. 1989 Oct;8(10):713–719. [PubMed] [Google Scholar]
  23. Keusch G. T., Donohue-Rolfe A., Jacewicz M. Shigella toxin and the pathogenesis of shigellosis. Ciba Found Symp. 1985;112:193–214. doi: 10.1002/9780470720936.ch11. [DOI] [PubMed] [Google Scholar]
  24. Keusch G. T., Grady G. F., Mata L. J., McIver J. The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. J Clin Invest. 1972 May;51(5):1212–1218. doi: 10.1172/JCI106915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Keusch G. T., Jacewicz M., Levine M. M., Hornick R. B., Kochwa S. Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J Clin Invest. 1976 Jan;57(1):194–202. doi: 10.1172/JCI108259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  27. Levine M. M., McEwen J., Losonsky G., Reymann M., Harari I., Brown J. E., Taylor D. N., Donohue-Rolfe A., Cohen D., Bennish M. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. J Clin Microbiol. 1992 Jul;30(7):1636–1641. doi: 10.1128/jcm.30.7.1636-1641.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Li A., Cam P. D., Islam D., Minh N. B., Huan P. T., Rong Z. C., Karlsson K., Lindberg G., Lindberg A. A. Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124. J Infect. 1994 Jan;28(1):11–23. doi: 10.1016/s0163-4453(94)94006-1. [DOI] [PubMed] [Google Scholar]
  29. Lindberg A. A., Cam P. D., Chan N., Phu L. K., Trach D. D., Lindberg G., Karlsson K., Kärnell A., Ekwall E. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays. Rev Infect Dis. 1991 Mar-Apr;13 (Suppl 4):S231–S237. doi: 10.1093/clinids/13.supplement_4.s231. [DOI] [PubMed] [Google Scholar]
  30. Linde G. A., Hammarström L., Persson M. A., Smith C. I., Sundqvist V. A., Wahren B. Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infect Immun. 1983 Oct;42(1):237–244. doi: 10.1128/iai.42.1.237-244.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. McIntyre T. M., Klinman D. R., Rothman P., Lugo M., Dasch J. R., Mond J. J., Snapper C. M. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med. 1993 Apr 1;177(4):1031–1037. doi: 10.1084/jem.177.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Meillet D., Raichvarg D., Tallet F., Savel J., Yonger J., Gobert J. G. Measurement of total, monomeric and polymeric IgA in human faeces by electroimmunodiffusion. Clin Exp Immunol. 1987 Jul;69(1):142–147. [PMC free article] [PubMed] [Google Scholar]
  33. Ménard R., Sansonetti P. J., Parsot C. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J Bacteriol. 1993 Sep;175(18):5899–5906. doi: 10.1128/jb.175.18.5899-5906.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Norhagen G., Engström P. E., Hammarström L., Söder P. O., Smith C. I. Immunoglobulin levels in saliva in individuals with selective IgA deficiency: compensatory IgM secretion and its correlation with HLA and susceptibility to infections. J Clin Immunol. 1989 Jul;9(4):279–286. doi: 10.1007/BF00918659. [DOI] [PubMed] [Google Scholar]
  35. Oaks E. V., Hale T. L., Formal S. B. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect Immun. 1986 Jul;53(1):57–63. doi: 10.1128/iai.53.1.57-63.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Oberhelman R. A., Kopecko D. J., Salazar-Lindo E., Gotuzzo E., Buysse J. M., Venkatesan M. M., Yi A., Fernandez-Prada C., Guzman M., León-Barúa R. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect Immun. 1991 Jul;59(7):2341–2350. doi: 10.1128/iai.59.7.2341-2350.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ogawa T., Kono Y., McGhee M. L., McGhee J. R., Roberts J. E., Hamada S., Kiyono H. Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva. Clin Exp Immunol. 1991 Feb;83(2):237–244. doi: 10.1111/j.1365-2249.1991.tb05621.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ryd M., Alfredsson H., Blomberg L., Andersson A., Lindberg A. A. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography. FEBS Lett. 1989 Dec 4;258(2):320–322. doi: 10.1016/0014-5793(89)81684-9. [DOI] [PubMed] [Google Scholar]
  39. Sansonetti P. J., Kopecko D. J., Formal S. B. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun. 1982 Mar;35(3):852–860. doi: 10.1128/iai.35.3.852-860.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sansonetti P. J., Ryter A., Clerc P., Maurelli A. T., Mounier J. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun. 1986 Feb;51(2):461–469. doi: 10.1128/iai.51.2.461-469.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Van de Verg L. L., Herrington D. A., Boslego J., Lindberg A. A., Levine M. M. Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations. J Infect Dis. 1992 Jul;166(1):158–161. doi: 10.1093/infdis/166.1.158. [DOI] [PubMed] [Google Scholar]
  42. Whitney C., Ant J., Moncla B., Johnson B., Page R. C., Engel D. Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun. 1992 Jun;60(6):2194–2200. doi: 10.1128/iai.60.6.2194-2200.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wilson M. E., Hamilton R. G. Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide. Infect Immun. 1992 May;60(5):1806–1812. doi: 10.1128/iai.60.5.1806-1812.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Winsor D. K., Jr, Mathewson J. J., DuPont H. L. Comparison of serum and fecal antibody responses of patients with naturally acquired Shigella sonnei infection. J Infect Dis. 1988 Nov;158(5):1108–1112. doi: 10.1093/infdis/158.5.1108. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES